Skip to main content
Erschienen in: Neurocritical Care 3/2016

12.07.2016 | Original Article

EEG Characteristics of Successful Burst Suppression for Refractory Status Epilepticus

verfasst von: Emily L. Johnson, Nirma Carballido Martinez, Eva K. Ritzl

Erschienen in: Neurocritical Care | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Refractory status epilepticus (RSE) is often treated with continuous intravenous medications with the goal of EEG burst suppression. Standard advice is to titrate medications to at least 10-s interburst intervals; however, this has not been shown to improve outcome. We examined EEG characteristics in patients treated with IV anesthetic therapy (IVAT) for RSE to determine which EEG characteristics were associated with successful lifting of IVAT (i.e., without recurrence of status epilepticus).

Methods

We screened the clinical continuous EEG database for adult patients treated with IVAT for RSE (excluding patients with anoxic injury). We measured the length of bursts and interburst intervals for each patient, calculated EEG burst suppression ratios, and graded bursts for the amount of epileptiform activity. We compared these characteristics in successful versus unsuccessful IVAT lifting attempts.

Results

We included 17 successful and 20 unsuccessful lifting attempts in 19 patients (5 used as a holdout validation set). The interburst intervals, burst suppression ratios, and length of bursts did not differentiate successful and unsuccessful lifting attempts; the amount of epileptiform activity in bursts correlated with success or failure to wean IVAT (p = 0.008). Maximum burst amplitude <125 μV had 84.6 % sensitivity and 61.1 % specificity for predicting successful lifting.

Conclusion

The length of interburst intervals and burst suppression did not predict successful termination of RSE in this small cohort. This may suggest that EEG characteristics, rather a strict interburst interval goal, could guide IVAT for RSE.
Literatur
1.
Zurück zum Zitat Hirsch LJ, Gaspard N. Status epilepticus. Continuum. 2013;19:794–7. Hirsch LJ, Gaspard N. Status epilepticus. Continuum. 2013;19:794–7.
2.
Zurück zum Zitat Allredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. NEJM. 2001;345:631–7.CrossRef Allredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. NEJM. 2001;345:631–7.CrossRef
3.
Zurück zum Zitat Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.CrossRefPubMed Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.CrossRefPubMed
4.
Zurück zum Zitat Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–702.CrossRefPubMed Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–702.CrossRefPubMed
5.
Zurück zum Zitat Rossetti AO, Reichhart MD, Schaller M, Despland P, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45:757–63.CrossRefPubMed Rossetti AO, Reichhart MD, Schaller M, Despland P, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45:757–63.CrossRefPubMed
6.
Zurück zum Zitat Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922–30.CrossRefPubMedPubMedCentral Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922–30.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Sahin M, Menache CC, Holmes GL, Riviello JJ Jr. Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children. Neurology. 2003;61:398–401.CrossRefPubMed Sahin M, Menache CC, Holmes GL, Riviello JJ Jr. Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children. Neurology. 2003;61:398–401.CrossRefPubMed
8.
Zurück zum Zitat Krishnamurthy KB, Drislane FB. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759–62.CrossRefPubMed Krishnamurthy KB, Drislane FB. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759–62.CrossRefPubMed
9.
Zurück zum Zitat Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72–7.CrossRefPubMed Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72–7.CrossRefPubMed
10.
Zurück zum Zitat Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40:2677–84.CrossRefPubMed Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40:2677–84.CrossRefPubMed
11.
Zurück zum Zitat Sutter R, Kaplan PW, Marsch S, Hammel EM, Ruegg S, Ziai WC. Early predictors of refractory status epilepticus: an international two-center study. Eur J Neurol. 2015;22:79–85.CrossRefPubMed Sutter R, Kaplan PW, Marsch S, Hammel EM, Ruegg S, Ziai WC. Early predictors of refractory status epilepticus: an international two-center study. Eur J Neurol. 2015;22:79–85.CrossRefPubMed
12.
13.
Zurück zum Zitat Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status epilepticus severity score: a tool to orient early treatment strategy. J Neurol. 2008;255:1561–6.CrossRefPubMed Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status epilepticus severity score: a tool to orient early treatment strategy. J Neurol. 2008;255:1561–6.CrossRefPubMed
14.
Zurück zum Zitat Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23.CrossRefPubMed Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23.CrossRefPubMed
15.
Zurück zum Zitat Bergey GK. Refractory status epilepticus: is EEG burst suppression an appropriate treatment target during drug-induced coma? what is the holy grail? Epilepsy Curr. 2006;6:119–20.CrossRefPubMedPubMedCentral Bergey GK. Refractory status epilepticus: is EEG burst suppression an appropriate treatment target during drug-induced coma? what is the holy grail? Epilepsy Curr. 2006;6:119–20.CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat Akrawi WP, Drummond JC, Kalkman CJ, Patel PM. A comparison of the electrophysiologic characteristics of EEG burst-suppression as produced by isoflurane, thiopental, etomidate, and Propofol. J Neurosurg Anesthesiol. 1996;8:40–6.CrossRefPubMed Akrawi WP, Drummond JC, Kalkman CJ, Patel PM. A comparison of the electrophysiologic characteristics of EEG burst-suppression as produced by isoflurane, thiopental, etomidate, and Propofol. J Neurosurg Anesthesiol. 1996;8:40–6.CrossRefPubMed
18.
Zurück zum Zitat Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
19.
Zurück zum Zitat Mani R, Arif H, Hirsch LJ, Gerard EE, LaRoche SM. Interrater reliability of ICU EEG research terminology. J Clin Neurophysiol. 2012;29:203–12.CrossRefPubMed Mani R, Arif H, Hirsch LJ, Gerard EE, LaRoche SM. Interrater reliability of ICU EEG research terminology. J Clin Neurophysiol. 2012;29:203–12.CrossRefPubMed
20.
Zurück zum Zitat Thompson SA, Hantus S. Highly epileptiform bursts are associated with seizure recurrence. J Clin Neurophysiol. 2016;33:66–71.CrossRefPubMed Thompson SA, Hantus S. Highly epileptiform bursts are associated with seizure recurrence. J Clin Neurophysiol. 2016;33:66–71.CrossRefPubMed
21.
Zurück zum Zitat Sutter R, Marsch S, Fuhr P, Kaplan P, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;25:656–64.CrossRef Sutter R, Marsch S, Fuhr P, Kaplan P, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;25:656–64.CrossRef
22.
Zurück zum Zitat Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85:495–500.CrossRef Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85:495–500.CrossRef
23.
Zurück zum Zitat Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.CrossRefPubMed Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.CrossRefPubMed
24.
Zurück zum Zitat Kang BS, Jung KH, Wu C, et al. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus. J Clin Neurosci. 2015;22:854–8.CrossRefPubMed Kang BS, Jung KH, Wu C, et al. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus. J Clin Neurosci. 2015;22:854–8.CrossRefPubMed
Metadaten
Titel
EEG Characteristics of Successful Burst Suppression for Refractory Status Epilepticus
verfasst von
Emily L. Johnson
Nirma Carballido Martinez
Eva K. Ritzl
Publikationsdatum
12.07.2016
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 3/2016
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-016-0294-2

Weitere Artikel der Ausgabe 3/2016

Neurocritical Care 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.